{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:29:19Z","timestamp":1743740959724,"version":"3.40.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,3]]},"DOI":"10.7759\/cureus.81655","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T02:54:14Z","timestamp":1743735254000},"source":"Crossref","is-referenced-by-count":0,"title":["Visual Performance of Individuals With and Without Meibomian Gland Dysfunction"],"prefix":"10.7759","author":[{"given":"Isabella","family":"Tunon-Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley K","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig JP","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al.. TFOS DEWS II definition and classification report. Ocul Surf. 2017, 15:276-83. 10.1016\/j.jtos.2017.05.008","journal-title":"Ocul Surf"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000998","article-title":"Mechanisms of visual disturbance in dry eye","volume":"35","author":"Koh S","year":"2016","unstructured":"Koh S. Mechanisms of visual disturbance in dry eye. Cornea. 2016, 35:S83-8. 10.1097\/ICO.0000000000000998","journal-title":"Cornea"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop E","year":"2011","unstructured":"Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011, 52:1938-78. 10.1167\/iovs.10-6997c","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.05.002","article-title":"The real reason for having a meibomian lipid layer covering the outer surface of the tear film - a review","volume":"137","author":"Millar TJ","year":"2015","unstructured":"Millar TJ, Schuett BS. The real reason for having a meibomian lipid layer covering the outer surface of the tear film - a review. Exp Eye Res. 2015, 137:125-38. 10.1016\/j.exer.2015.05.002","journal-title":"Exp Eye Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00669-1","article-title":"Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape","volume":"12","author":"Sheppard JD","year":"2023","unstructured":"Sheppard JD, Nichols KK. Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape. Ophthalmol Ther. 2023, 12:1397-418. 10.1007\/s40123-023-00669-1","journal-title":"Ophthalmol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson JD","year":"2011","unstructured":"Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011, 52:1930-7. 10.1167\/iovs.10-6997b","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.10.009","article-title":"Sustained gazing causes measurable decline in visual function of patients with dry eye","volume":"210","author":"Akpek EK","year":"2020","unstructured":"Akpek EK, Karakus S, Ramulu PY, Mathews PM. Sustained gazing causes measurable decline in visual function of patients with dry eye. Am J Ophthalmol. 2020, 210:107-15. 10.1016\/j.ajo.2019.10.009","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2021.10.007","article-title":"The vision-related burden of dry eye","volume":"23","author":"Morthen MK","year":"2022","unstructured":"Morthen MK, Magno MS, Utheim TP, Snieder H, Jansonius N, Hammond CJ, Vehof J. The vision-related burden of dry eye. Ocul Surf. 2022, 23:207-15. 10.1016\/j.jtos.2021.10.007","journal-title":"Ocul Surf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1108549","article-title":"Binocular dynamic visual acuity in dry eye disease patients","volume":"17","author":"Ren X","year":"2023","unstructured":"Ren X, Wang Y, Wu T, Jing D, Li X. Binocular dynamic visual acuity in dry eye disease patients. Front Neurosci. 2023, 17:1108549. 10.3389\/fnins.2023.1108549","journal-title":"Front Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092473","article-title":"Post-blink blur time-a simple test to detect dry eye-related visual disturbances","volume":"13","author":"Petri\u010dek I","year":"2024","unstructured":"Petri\u010dek I, Le\u0161in Ga\u0107ina D, Tomi\u0107 M, Bulum T, Be\u0161li\u0107 I, Vidas Pauk S. Post-blink blur time-a simple test to detect dry eye-related visual disturbances. J Clin Med. 2024, 13:2473. 10.3390\/jcm13092473","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239271","article-title":"Defining dry eye from a clinical perspective","volume":"21","author":"Tsubota K","year":"2020","unstructured":"Tsubota K, Pflugfelder SC, Liu Z, et al.. Defining dry eye from a clinical perspective. Int J Mol Sci. 2020, 21:9271. 10.3390\/ijms21239271","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12234","article-title":"Microfluctuations in accommodation: an update on their characteristics and possible role","volume":"35","author":"Charman WN","year":"2015","unstructured":"Charman WN, Heron G. Microfluctuations in accommodation: an update on their characteristics and possible role. Ophthalmic Physiol Opt. 2015, 35:476-99. 10.1111\/opo.12234","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000490","article-title":"Optimizing reading tests for dry eye disease","volume":"34","author":"Ousler GW 3rd","year":"2015","unstructured":"Ousler GW 3rd, Rodriguez JD, Smith LM, Lane KJ, Heckley C, Angjeli E, Abelson MB. Optimizing reading tests for dry eye disease. Cornea. 2015, 34:917-21. 10.1097\/ICO.0000000000000490","journal-title":"Cornea"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-308237","article-title":"Functional impairment of reading in patients with dry eye","volume":"101","author":"Mathews PM","year":"2017","unstructured":"Mathews PM, Ramulu PY, Swenor BS, Utine CA, Rubin GS, Akpek EK. Functional impairment of reading in patients with dry eye. Br J Ophthalmol. 2017, 101:481-6. 10.1136\/bjophthalmol-2015-308237","journal-title":"Br J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8284","article-title":"Standardized assessment of reading performance: the new International Reading Speed Texts iReSt","volume":"53","author":"Trauzettel-Klosinski S","year":"2012","unstructured":"Trauzettel-Klosinski S, Dietz K. Standardized assessment of reading performance: the new International Reading Speed Texts iReSt. Invest Ophthalmol Vis Sci. 2012, 53:5452-61. 10.1167\/iovs.11-8284","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling G","year":"2011","unstructured":"Geerling G, Tauber J, Baudouin C, et al.. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011, 52:2050-64. 10.1167\/iovs.10-6997g","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones L","year":"2017","unstructured":"Jones L, Downie LE, Korb D, et al.. TFOS DEWS II management and therapy report. Ocul Surf. 2017, 15:575-628. 10.1016\/j.jtos.2017.05.006","journal-title":"Ocul Surf"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.009","article-title":"TFOS DEWS II clinical trial design report","volume":"15","author":"Novack GD","year":"2017","unstructured":"Novack GD, Asbell P, Barabino S, et al.. TFOS DEWS II clinical trial design report. Ocul Surf. 2017, 15:629-49. 10.1016\/j.jtos.2017.05.009","journal-title":"Ocul Surf"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0064","article-title":"Exploring signs and symptoms associated with meibomian gland dysfunction for use as clinical trial endpoints","volume":"39","author":"Ajouz L","year":"2023","unstructured":"Ajouz L, Nguyen A, Zhao C, Robinson MR, Nichols KK. Exploring signs and symptoms associated with meibomian gland dysfunction for use as clinical trial endpoints. J Ocul Pharmacol Ther. 2023, 39:611-21. 10.1089\/jop.2023.0064","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.10.22","article-title":"Relationship between human meibum lipid composition and the severity of meibomian gland dysfunction: a spectroscopic analysis","volume":"64","author":"Nagar S","year":"2023","unstructured":"Nagar S, Ajouz L, Nichols KK, et al.. Relationship between human meibum lipid composition and the severity of meibomian gland dysfunction: a spectroscopic analysis. Invest Ophthalmol Vis Sci. 2023, 64:22. 10.1167\/iovs.64.10.22","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2024.0063","article-title":"Changes in human meibum lipid composition related to the presence and severity of meibomian gland dysfunction","volume":"40","author":"Nguyen A","year":"2024","unstructured":"Nguyen A, Naidoo KK, Ajouz L, Xu X, Zhao C, Robinson MR, Borchman D. Changes in human meibum lipid composition related to the presence and severity of meibomian gland dysfunction. J Ocul Pharmacol Ther. 2024, 40:562-70. 10.1089\/jop.2024.0063","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.52768\/AnnOphthalmolVisSci\/1045","article-title":"Meibomian gland structure in participants with and without meibomian gland dysfunction","volume":"7","author":"Tunon-Robinson I","year":"2024","unstructured":"Tunon-Robinson I, Xu X, Zhao C, Nguyen A. Meibomian gland structure in participants with and without meibomian gland dysfunction. Ann Ophthalmol Vis Sci. 2024, 7:1045. 10.52768\/AnnOphthalmolVisSci\/1045","journal-title":"Ann Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.52768\/AnnOphthalmolVisSci\/1044","article-title":"Tear film lipid layer thickness in subjects with increasing severity of meibomian gland dysfunction","volume":"7","author":"Ajouz L","year":"2024","unstructured":"Ajouz L, Nguyen A, Zhao C, Ho C, Robinson MR. Tear film lipid layer thickness in subjects with increasing severity of meibomian gland dysfunction. Ann Ophthalmol Vis Sci. 2024, 7:1044. 10.52768\/AnnOphthalmolVisSci\/1044","journal-title":"Ann Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0080","article-title":"Evaluation of the impact of meibomian gland dysfunction using a novel patient-reported outcome instrument","volume":"40","author":"Ajouz L","year":"2024","unstructured":"Ajouz L, Hallak J, Naik R, Nguyen A, Zhao C, Robinson MR, Nichols KK. Evaluation of the impact of meibomian gland dysfunction using a novel patient-reported outcome instrument. J Ocul Pharmacol Ther. 2024, 40:48-56. 10.1089\/jop.2023.0080","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson A","year":"2011","unstructured":"Tomlinson A, Bron AJ, Korb DR, et al.. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011, 52:2006-49. 10.1167\/iovs.10-6997f","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181d87e04","article-title":"Novel method for analyzing Snellen visual acuity measurements","volume":"30","author":"Gregori NZ","year":"2010","unstructured":"Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing Snellen visual acuity measurements. Retina. 2010, 30:1046-50. 10.1097\/IAE.0b013e3181d87e04","journal-title":"Retina"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38196","article-title":"Reading speed using the International Reading Speed Texts in a normal Canadian cohort","volume":"15","author":"Lamoureux D","year":"2023","unstructured":"Lamoureux D, Yeo S, Bhambhwani V. Reading speed using the International Reading Speed Texts in a normal Canadian cohort. Cureus. 2023, 15:e38196. 10.7759\/cureus.38196","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.12482","article-title":"Visual and personal characteristics are associated with reading performance in normally sighted adults","volume":"100","author":"Brussee T","year":"2017","unstructured":"Brussee T, van Nispen RM, van Rens GH. Visual and personal characteristics are associated with reading performance in normally sighted adults. Clin Exp Optom. 2017, 100:270-7. 10.1111\/cxo.12482","journal-title":"Clin Exp Optom"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/02537176211021280","article-title":"The ceiling effect, the floor effect, and the importance of active and placebo control arms in randomized controlled trials of an investigational drug","volume":"43","author":"Andrade C","year":"2021","unstructured":"Andrade C. The ceiling effect, the floor effect, and the importance of active and placebo control arms in randomized controlled trials of an investigational drug. Indian J Psychol Med. 2021, 43:360-1. 10.1177\/02537176211021280","journal-title":"Indian J Psychol Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23500","article-title":"Irregular astigmatism and higher-order aberrations in eyes with dry eye disease","volume":"59","author":"Koh S","year":"2018","unstructured":"Koh S. Irregular astigmatism and higher-order aberrations in eyes with dry eye disease. Invest Ophthalmol Vis Sci. 2018, 59:DES36-40. 10.1167\/iovs.17-23500","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S469300","article-title":"Impact of TearCare on reading speed in patients with dry eye disease","volume":"18","author":"Feng Y","year":"2024","unstructured":"Feng Y, Venkateswaran N, Steele A, Rosenberg ED, Gupta PK. Impact of TearCare on reading speed in patients with dry eye disease. Clin Ophthalmol. 2024, 18:2873-8. 10.2147\/OPTH.S469300","journal-title":"Clin Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997e","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD","volume":"52","author":"Schaumberg DA","year":"2011","unstructured":"Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011, 52:1994-2005. 10.1167\/iovs.10-6997e","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346483-visual-performance-of-individuals-with-and-without-meibomian-gland-dysfunction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T02:54:16Z","timestamp":1743735256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346483-visual-performance-of-individuals-with-and-without-meibomian-gland-dysfunction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.81655","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}